found that metformin effectively inhibited nasopharyngeal carcinoma cell proliferation by inducing G1 cell cycle arrest, downregulating cyclin D1, and suppressing mTORC1 signaling through AMPK activation [154]. This evidence concerns the gene CCND1 and nasopharyngeal carcinoma.